- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.10 Å
- Oligo State
- homo-trimer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 3 residues within 4Å:- Chain A: A.706, E.1072, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.16: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.27: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 2 residues within 4Å:- Chain A: I.1132, N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 1 residues within 4Å:- Chain B: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.28: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.29: 1 residues within 4Å:- Chain C: N.1134
No protein-ligand interaction detected (PLIP)- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.30: 3 residues within 4Å:- Chain A: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: K.147, N.149, S.151
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.234
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: G.339, F.342, N.343
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain A: N.1158
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: K.147, N.148, N.149
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: G.232, N.234
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain B: H.655, V.656, N.657
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain B: Y.1155, N.1158
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: N.145, N.148, N.149
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain C: P.330, N.331, I.332, Q.580
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: G.339, F.342, N.343
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain A: D.796
- Chain C: N.709
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain C: Y.1155, N.1158
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-07-12
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.10 Å
- Oligo State
- homo-trimer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-07-12
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C